Hemerion

Developer of therapeutic solutions for the treatment of cancer

placeVilleneuve D Ascq, Hauts De France, France calendar_todayFounded 2020 groups14 employees language hemerion.com

Social engagement

Social engagement: 4.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Nord France Amorquage, Finovam Gestion.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%

Recent activity

2 Jul 2026
Event
VivaTech 2026 | Innovation vs. Cancer Accueillie
20 Jun 2026
Event
BIO International Convention
19 Jun 2026
Event
VivaTech 2026
Coming soon